Shareholder Reports

If you would like physical copies of any document, please call us at 877-771-EVEN (3836) or email us at info@eventideinvestments.com.

• Eventide Funds Annual Financial Statements and Additional Information (6/30/2026)

• Eventide Funds Semi-Annual Financial Statements and Additional Information (12/31/2025)

• Eventide Balanced Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Core Bond Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Dividend Growth Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Exponential Technologies Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Gilead Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Healthcare & Life Sciences Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Large Cap Focus Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Limited-Term Bond Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Balanced Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Core Bond Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Dividend Growth Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Exponential Technologies Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Gilead Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Healthcare & Life Sciences Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Large Cap Focus Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Limited-Term Bond Fund

  • Class I

  • Class A

  • Class C

  • Class N

• Eventide Funds Schedule of Investments (06/30/2026)

• Eventide Funds Schedule of Investments (03/31/2026)

• Eventide Funds Schedule of Investments (12/31/2025)

• Eventide Funds Schedules of Investments (09/30/2025)

• Eventide Funds Annual Form N-PX (Non-Voting) (06/30/2026)

• Eventide Funds Annual Form N-PX (Proxy Voting) (06/30/2026)

• Eventide Gilead, Healthcare & Life Sciences, and Exponential Technologies Fund Holdings (10/16/2026)